Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
29.04
+0.11 (0.38%)
At close: Jan 2, 2026, 4:00 PM EST
28.93
-0.11 (-0.39%)
After-hours: Jan 2, 2026, 6:32 PM EST
Mersana Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$30.38
Upside
+4.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $36 → $31 | Strong Buy → Hold | Downgrades | $36 → $31 | +5.89% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $250 → $36 | Strong Buy | Maintains | $250 → $36 | +23.97% | Aug 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $125 → $30 | Strong Buy | Maintains | $125 → $30 | +3.31% | Aug 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $225 → $250 | Strong Buy | Maintains | $225 → $250 | +760.88% | May 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $125 | Strong Buy | Reiterates | $125 | +330.44% | May 16, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 6, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $150 → $125 | Strong Buy | Maintains | $150 → $125 | +330.44% | Aug 27, 2024 |
| Baird | Baird | Hold Maintains $100 → $75 | Hold | Maintains | $100 → $75 | +158.26% | Aug 14, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $125 | Sell → Hold | Upgrades | $125 | +330.44% | Mar 19, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades $50 → $175 | Hold → Buy | Upgrades | $50 → $175 | +502.62% | Feb 29, 2024 |
| Truist Securities | Truist Securities | Hold → Strong Buy Upgrades $225 | Hold → Strong Buy | Upgrades | $225 | +674.79% | Feb 29, 2024 |
| Baird | Baird | Hold Maintains $25 → $125 | Hold | Maintains | $25 → $125 | +330.44% | Feb 29, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $175 | Hold → Strong Buy | Upgrades | $175 | +502.62% | Feb 29, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $25 → $125 | Hold → Strong Buy | Upgrades | $25 → $125 | +330.44% | Dec 4, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.